{
  "url": "https://www.law.cornell.edu/regulations/new-york/10-NYCRR-2.2",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 2.2 - Definitions",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 2.2 - Definitions\n\nState Regulations\n\nDefinitions shall include the following: (a) For public health reporting purposes, hospital-associated infections shall include\nan outbreak\nor increased incidence\nof disease due to microbiological agents or their toxic products occurring in\npatients or persons working in the hospital. Any non-reportable\nhospital-associated infections must be handled nonetheless by hospitals and\ntheir infection control committees. (b) A\ncase\nis defined as a\nperson\nwho has\nbeen diagnosed to have a particular disease or condition. The diagnosis may be\nbased solely on clinical judgment or solely on laboratory evidence, or on both\ncriteria. (c) A\nsuspected case\nis\ndefined as a\nperson\nwho has been diagnosed as likely to have a particular\ndisease or condition. The suspected diagnosis may be based solely on signs and\nsymptoms, or solely on laboratory evidence, or both criteria. (d) An outbreak\nis defined as an increased\nincidence of disease above its expected or baseline level. As the number of\ncases which indicate the presence of\nan outbreak\nvary according to the\ninfectious agent, size and type of population exposed, previous\nexposure\nor\nlack of\nexposure\nto the disease, and time and place of occurrence, the expected\nor baseline level of disease shall be assessed by hospitals and their infection\ncontrol committees as directed in section\n405.11\nof this Title. While\nan\noutbreak\nusually involves several cases of illness (e.g., food-borne poisoning, influenza), it may consist of just one\ncase\nfor certain rare and/or serious\ndiseases (e.g., botulism, measles). (e) As used in this Part, local health\nauthority is defined as the health officer of a county, part-county, city, town, village, consolidated health district, or any county or public health\ndirector having all the powers and duties prescribed in section\n352\nof the\n\nPublic Health Law. (f) As used in\nthis Part, the term approved laboratory or laboratory approved for the\nexamination shall mean, as the\ncase\nmay be, a laboratory possessing either a\ncertificate of approval for the specified examination issued by the\n\nState\n\nCommissioner\nof Health under the authority of title 1 of article 5 of the\n\nPublic Health Law or a permit for the specified examination issued by said\ncommissioner\nunder the authority of title 5 of said article. (g) As used in this Part, the term vaccinia\ndisease shall mean: (1)\npersons with vaccinia\ninfection due to contact transmission; and\n(2)\npersons with the following complications\nfrom vaccination: eczema vaccinatum, erythema multiforme major or\n\nStevens-Johnson syndrome, fetal vaccinia, generalized vaccinia, inadvertent\ninoculation, ocular vaccinia, post-vaccinial encephalitis or encephalomyelitis, progressive vaccinia, pyogenic infection of the vaccination site, and any other\nserious adverse events (i.e., those resulting in hospitalization, permanent\ndisability, life-threatening illness or death). Notes\nN.Y. Comp. Codes R. & Regs. Tit. 10\nยง\n2.2\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 37369
}